Assignee

Calando Pharmaceuticals, Inc.

Patents = 9

Forward Citations = 181

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

9 inventors (with patents filed for the assignee):

Calando Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing novel targeted therapies for the treatment of cancer. Using its proprietary RNA interference (RNAi) technology, Calando is dedicated to delivering personalized medicine solutions that improve patient outcomes and quality of life. With a strong pipeline of innovative oncology products, Calando is committed to advancing the field of precision medicine and revolutionizing cancer treatment.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com